TERN
Terns Pharmaceuticals Inc
NASDAQ: TERN · HEALTHCARE · BIOTECHNOLOGY
$52.92
-0.04% today
Updated 2026-04-29
Market cap
$6.11B
P/E ratio
—
P/S ratio
302.64x
EPS (TTM)
$-1.03
Dividend yield
—
52W range
$3 – $53
Volume
6.6M
Terns Pharmaceuticals Inc (TERN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $89.07M | $23.90M | $92.29M | $168.07M | $287.03M | $268.52M | $363.93M |
| Cash & equivalents | $82.52M | $12.33M | $74.85M | $47.70M | $143.24M | $79.93M | $161.44M |
| Current assets | $88.48M | $22.22M | $90.87M | $166.93M | $285.19M | $267.43M | $362.11M |
| Total liabilities | $16.84M | $5.58M | $23.70M | $7.77M | $10.08M | $13.15M | $18.06M |
| Current liabilities | $2.38M | $4.95M | $22.82M | $6.82M | $8.47M | $11.94M | $15.65M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $72.23M | $4.21M | $68.59M | $160.30M | $276.94M | $255.37M | $345.87M |
| Retained earnings | $-23.25M | $-91.86M | $-131.91M | $-182.07M | $-242.42M | $-332.63M | $-421.48M |
| Accounts receivable | — | — | $12.72M | — | — | — | — |
| Inventory | — | — | $2.97M | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |